Diabetes warning to be introduced on statin labelling in the US

Links shared publicly online about this topic.

0
total visits

Diabetes warning to be introduced on statin labelling in the US

The Food and Drug Administration (FDA) in the United States has said they are to introduce new warnings on the labels of statins about their potential for increasing blood sugar levels and also causing some memory loss in patients. The health regulators have announced that the statins, including Lipitor from Pfizer, Crestor from AstraZeneca, and Zocor from Merck and Co, are to have changes to their safety information to warn patients about the possible dangers. The FDA argued that the new warnin

View full resource at diabetes.co.uk

Tags: Diabetes, Blood Sugar, Diet and Nutrition, Drug, Healthy Living, Memory, FDA

Most Recently Shared on February 29, 2012 at 4:31 pm By:

DiabetesMine

RT @diabetescouk: Diabetes warning to be introduced on statin labelling in the US http://t.co/m3T8G934

3 months ago...

Retweet

Favorite

Also Shared By:

Amy Tenderich

FDA adds diabetes, memory loss warnings to statins | Reuters

reuters.com — “(Reuters) - U.S. health regulators will add warnings to the labels of widely used cholesterol lowering drugs, such as Lipitor, to indicate that they may raise levels of blood sugar and could cause memory” View full resource at reuters.com

Most Recently Shared on March 26, 2012 at 7:12 pm By:

Reuters Health Health News

FDA adds diabetes, memory loss warnings to statins http://t.co/K8LawBa8

2 months ago...

Retweet

Favorite

FDA adds diabetes, memory loss warnings to statins | Reuters

reuters.com — “(Reuters) - Health regulators are adding warnings to the labels of widely used cholesterol lowering drugs, such as Lipitor, to say they may raise levels of blood sugar and could cause memory loss.The” View full resource at reuters.com